Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Glioblastoma multiforme (GBM) is a lethal brain tumor characterized by intense apoptosis resistance and extensive necrosis. Bcl2L12 (for Bcl2-like 12) is a cytoplasmic and nuclear protein that is overexpressed in primary GBM and functions to inhibit post-mitochondrial apoptosis signaling. Here, we show that nuclear Bcl2L12 physically and functionally interacts with the p53 tumor suppressor, as evidenced by the capacity of Bcl2L12 to (1) enable bypass of replicative senescence without concomitant loss of p53 or p19Arf, (2) inhibit p53-dependent DNA damage-induced apoptosis, (3) impede the capacity of p53 to bind some of its target gene promoters, and (4) attenuate endogenous p53-directed transcriptomic changes following genotoxic stress. Correspondingly, The Cancer Genome Atlas profile and tissue protein analyses of human GBM specimens show significantly lower Bcl2L12 expression in the setting of genetic p53 pathway inactivation. Thus, Bcl2L12 is a multifunctional protein that contributes to intense therapeutic resistance of GBM through its ability to operate on two key nodes of cytoplasmic and nuclear signaling cascades.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“…DEVELOPMENT 24:2194–2204 2010 by Cold Spring Harbor Laboratory Press ISSN 0890-9369/10; www.genesdev.org and indirectly through interaction with the E2F1 and Rb family proteins p107 and Rb1 (Dubs-Poterszman et al. 1995; Martin et al. 1995; Xiao et al. 1995; Haupt et al. 1997; Kubbutat et al. 1997).”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“…documenting ATM/ATR-mediated phosphorylation of Ser15 (Ser18 in murine p53) as a pivotal p53 stabilization pathway in response to DNA damage (Kastan et al. 1992; Lu and Lane 1993; Siliciano et al. 1997; Khanna et al. 1998; Nakagawa et al. 1999; Tibbetts et al. 1999), we found reduced Ser18…”
BackgroundMalignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316 · cited 1×
“…inhibits p53 transcription and enhances the ubiquitin ligase activity of Mdm2, is amplified in 4% of GBM in the absence of TP53 mutation and Mdm2 amplification (Shvarts et al. 1996; Riemenschneider et al. 1999; Gu et al. 2002; Linares et al. 2003; The Cancer Genome Atlas Research Network 2008).”
BackgroundSelf-citationPUMA, a Novel Proapoptotic Gene, Is Induced by p53
Nakano, K., & Vousden, K. H. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00214-3 · Cited by 2,315 · cited 1×
“…independent transfectants) retrovirally transduced with pBabe or pBabe-Bcl2L12V5 according to established protocols using the pBabe/pCL system (Naviaux et al. 1996) were passaged into six-well plates every 3 d. Senescence was determined using the SA-b-Gal staining kit (Abcam) according to the…”
MethodNoxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112 · cited 10×
“Together with the modulation of other factors regulating p53 stability (such as JNK, pRb, and cAbl signaling) (for review, see Ashcroft and Vousden 1999), we propose that reduced p53 phosphorylation in Bcl2L12expressing cells in the setting of intact Mdm2 may contribute to the reduction in p53 levels and effects on ov…”
BackgroundInfluentialDirect Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108 · cited 2×
“…their prominent roles in glioma pathogenesis, Bcl2L12’s nuclear localization, and the capacity of other Bcl-2 family proteins (e.g., Bax, Bak, Bcl-xL, and Bcl-2) to interact with and functionally impact p53 (Mihara et al. 2003; Chipuk et al. 2004, 2005; Leu et al. 2004; Petros et al. 2004).”
BackgroundThe p53 pathway: positive and negative feedback loops
Harris, S. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208615 · Cited by 1,967 · cited 1×
“…DEVELOPMENT 24:2194–2204 2010 by Cold Spring Harbor Laboratory Press ISSN 0890-9369/10; www.genesdev.org and indirectly through interaction with the E2F1 and Rb family proteins p107 and Rb1 (Dubs-Poterszman et al. 1995; Martin et al. 1995; Xiao et al. 1995; Haupt et al. 1997; Kubbutat et al. 1997).”
BackgroundAmplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585 · cited 2×
“Bypass of the senescence checkpoint in primary murine cells has been shown to require loss of p53 or p19Arf (Serrano et al. 1996; Kamijo et al. 1997).”
BackgroundSelf-citationTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521 · cited 1×
“Other mutations affect p14Arf (p19Arf in mouse) (Kamijo et al. 1997), which blocks the degradation of p53 through direct binding to Mdm2, thereby stabilizing p53 (Kamijo et al. 1997; Pomerantz et al. 1998; Stott et al. 1998; Zhang et al. 1998).”
BackgroundSelf-citationp53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa
Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M., & Strasser, A. (2003) · Science · doi:10.1126/science.1090072 · Cited by 1,327
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286
A role for ATR in the DNA damage-induced phosphorylation of p53
Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S.-Y., Taya, Y., Prives, C., & Abraham, R. T. (1999) · Genes & Development · doi:10.1101/gad.13.2.152 · Cited by 1,046 · cited 1×
“…pathway in response to DNA damage (Kastan et al. 1992; Lu and Lane 1993; Siliciano et al. 1997; Khanna et al. 1998; Nakagawa et al. 1999; Tibbetts et al. 1999), we found reduced Ser18 phosphorylation in murine Bcl2L12-transduced astrocytic cultures and enhanced Ser15 phosphorylation in…”
BackgroundDNA damage induces phosphorylation of the amino terminus of p53
Siliciano, J. D., Canman, C. E., Taya, Y., Sakaguchi, K., Appella, E., & Kastan, M. B. (1997) · Genes & Development · doi:10.1101/gad.11.24.3471 · Cited by 818 · cited 1×
“…of Ser15 (Ser18 in murine p53) as a pivotal p53 stabilization pathway in response to DNA damage (Kastan et al. 1992; Lu and Lane 1993; Siliciano et al. 1997; Khanna et al. 1998; Nakagawa et al. 1999; Tibbetts et al. 1999), we found reduced Ser18 phosphorylation in murine…”
BackgroundMitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex
Leu, J. I.-J., Dumont, P., Hafey, M., Murphy, M. E., & George, D. L. (2004) · Nature Cell Biology · doi:10.1038/ncb1123 · Cited by 770
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Zheng, H., Ying, H., Yan, H., Kimmelman, A. C., Hiller, D. J., Chen, A.-J., Perry, S. R., Tonon, G., Chu, G. C., Ding, Z., et al. (2008) · Nature · doi:10.1038/nature07443 · Cited by 767 · cited 4×
“Recent resequencing efforts, together with populationbased and TCGA studies, established significant occurrences of TP53 mutations in not only secondary, but also primary, GBM (Ohgaki et al. 2004; Fukushima et al. 2006; The Cancer Genome Atlas Research Network 2008; Zheng et al. 2008).”
BackgroundSelf-citationAlcantara Llaguno, S., Chen, J., Kwon, C.-H., Jackson, E. L., Li, Y., Burns, D. K., Alvarez-Buylla, A., & Parada, L. F. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.006 · Cited by 694 · cited 3×
“…in GBM (such as Mdm2, Mdm4, and p19Arf), together with functional and mouse modeling studies (e.g., Kwon et al. 2008; Zheng et al. 2008; Alcantara Llaguno et al. 2009), have established the p53 signaling network as an integral tumor suppressor pathway in GBM pathogenesis that impacts diverse…”
BackgroundASPP Proteins Specifically Stimulate the Apoptotic Function of p53
Samuels-Lev, Y., O'Connor, D. J., Bergamaschi, D., Trigiante, G., Hsieh, J.-K., Zhong, S., Campargue, I., Naumovski, L., Crook, T., & Lu, X. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00367-7 · Cited by 664 · cited 1×
“…status, such as acetylation (for review, see Lee and Gu 2010); and (3) its complex formation with cofactors capable of enhancing the interaction with certain promoter elements, such as p63/p73 (Flores et al. 2002), Bbp (Iwabuchi et al. 1998), and ASPP proteins (Samuels-Lev et al. 2001).”
BackgroundMDMX: a novel p53‐binding protein with some functional properties of MDM2.
Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00919.x · Cited by 648 · cited 1×
“…inhibits p53 transcription and enhances the ubiquitin ligase activity of Mdm2, is amplified in 4% of GBM in the absence of TP53 mutation and Mdm2 amplification (Shvarts et al. 1996; Riemenschneider et al. 1999; Gu et al. 2002; Linares et al. 2003; The Cancer Genome Atlas Research Network 2008).”
BackgroundHdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
Linares, L. K., Hengstermann, A., Ciechanover, A., Müller, S., & Scheffner, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2030930100 · Cited by 361 · cited 1×
“…inhibits p53 transcription and enhances the ubiquitin ligase activity of Mdm2, is amplified in 4% of GBM in the absence of TP53 mutation and Mdm2 amplification (Shvarts et al. 1996; Riemenschneider et al. 1999; Gu et al. 2002; Linares et al. 2003; The Cancer Genome Atlas Research Network 2008).”
BackgroundThe multiple levels of regulation by p53 ubiquitination
Lee, J. T., & Gu, W. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.77 · Cited by 289 · cited 2×
“…their prominent roles in glioma pathogenesis, Bcl2L12’s nuclear localization, and the capacity of other Bcl-2 family proteins (e.g., Bax, Bak, Bcl-xL, and Bcl-2) to interact with and functionally impact p53 (Mihara et al. 2003; Chipuk et al. 2004, 2005; Leu et al. 2004; Petros et al. 2004).”
Background
Cited by
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Tomczak, K., Czerwińska, P., & Wiznerowicz, M. (2015) · Współczesna Onkologia · doi:10.5114/wo.2014.47136 · Cited by 3,492
Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma
Jensen, S. A., Day, E. S., Ko, C. H., Hurley, L. A., Luciano, J. P., Kouri, F. M., Merkel, T. J., Luthi, A. J., Patel, P. C., Cutler, J. I., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006839 · Cited by 592
Self-citationKumthekar, P., Ko, C. H., Paunesku, T., Dixit, K., Sonabend, A. M., Bloch, O., Tate, M., Schwartz, M., Zuckerman, L., Lezon, R., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb3945 · Cited by 345
Self-citationCurrent understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
England, B., Huang, T., & Karsy, M. (2013) · Tumor Biology · doi:10.1007/s13277-013-0871-3 · Cited by 163
Metadata
- Authors
- Stegh, A. H., Brennan, C., Mahoney, J. A., Forloney, K. L., Jenq, H. T., Luciano, J. P., Protopopov, A., Chin, L., & DePinho, R. A.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2010-09-13
- Volume
- 24
- Issue
- 19
- Pages
- 2194-2204
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2119159165
- Cited by
- 85
- References
- 24
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.